-
Trichostatin A (TSA): HDAC Inhibitor Guide
2026-08-14
Trichostatin A (TSA) is a reversible HDAC inhibitor used to study histone acetylation, cell-cycle control, differentiation, and cancer biology. Product data report breast cancer cell-growth inhibition at an approximate IC50 of 124.4 nM, while a separate cardiomyocyte study provides chromatin-context evidence rather than direct evidence of TSA efficacy.
-
How Near-Death Tumor Cells Seed Metastasis
2026-08-13
Conod, Silvano, and Ruiz i Altaba identify impending cell death as an active source of prometastatic tumor states rather than merely a mechanism of tumor-cell elimination. Their work defines PAMEs, links their formation to ER stress and nuclear reprogramming, and shows how cytokine-mediated recruitment of neighboring PIMs creates a metastasis-supportive ecosystem.
-
REV1–DHX36 Coordination of G-Quadruplex Tolerance
2026-08-13
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings define a two-tier mechanism for G4 tolerance and connect REV1 deficiency with increased ATM/ATR signaling and sensitivity to G4-stabilizing agents.
-
SERCA2 Dysfunction, ROS, and Pulmonary Remodeling
2026-08-12
The reference study identifies SERCA2 dysfunction as an upstream driver of pulmonary vascular inflammation, oxidative stress, and remodeling through suppression of the PPARγ/PGC1α/Nrf2 axis. Its combination of a SERCA2 C674S mouse model, pulmonary artery smooth muscle cell experiments, and mechanistically directed rescue treatments provides a framework for connecting calcium dysregulation with redox-dependent vascular disease.
-
Norepinephrine, K⁺ Channels, and Renal Flow in Sepsis
2026-08-12
The reference study examined how norepinephrine and phenylephrine interact with renal vascular potassium channels in septic rats, combining isolated kidney perfusion with in vivo renal blood-flow measurements. Its central finding is that pharmacological blockade of Kir6.1-containing ATP-sensitive or KCa1.1 calcium-activated potassium channels can worsen catecholamine-associated renal hypoperfusion, emphasizing that systemic vasopressor responses may not predict kidney-specific effects.
-
OM-MSCs Protect Golgi Function After Cerebral IRI
2026-08-11
The reference study identifies a mechanistic link between olfactory mucosa mesenchymal stem cells, PEDF secretion, and Golgi apparatus stress after cerebral ischemia/reperfusion injury. Using OGD/R and reversible MCAO models, it shows that OM-MSCs reduce GOLPH3-associated stress, oxidative and calcium disturbances, Golgi fragmentation, and excessive autophagy through PI3K/Akt/mTOR pathway activation.
-
CAY10499 in Translational Immunometabolism
2026-08-11
CAY10499 offers a practical way to interrogate HSL- and MGL-dependent lipid flux alongside the ACLY-driven metabolic reprogramming recently linked to tumor-associated macrophages in hepatocellular carcinoma. This thought-leadership perspective translates those findings into assay strategy while distinguishing mechanistic opportunity from evidence that remains preliminary.
-
JNJ-26481585 (Quisinostat) Workflow Guide
2026-08-10
Build more informative HDAC inhibition experiments with JNJ-26481585 (Quisinostat), from concentration-response screening to apoptosis, histone acetylation, and resistance assays. The workflow connects broad anti-proliferative activity with the TRIM21–ERK1/2 findings reported in pituitary adenoma models.
-
Removing Pollen Interference in Bioaerosol EEM
2026-08-09
Zhang and colleagues developed a spectral feature-transformation and random-forest workflow to reduce pollen interference during hazardous bioaerosol classification using excitation–emission matrix fluorescence spectroscopy. Fast Fourier transformation produced the strongest reported gain, raising classification accuracy to 89.24% and improving separation of several bacterial and toxin-related samples, according to the reference study.
-
Haptotactic Motion of Multivalent Vesicles
2026-08-08
Sleath and colleagues developed a synthetic giant unilamellar vesicle system to test how multivalent adhesion drives passive motion along ligand-density gradients. Their combined experiments, numerical modeling, and theory show that directional migration depends on both molecular binding strength and vesicle size, providing design principles for biomimetic motile systems.
-
Asunaprevir: From Protease Biology to Assay Design
2026-08-07
Asunaprevir (BMS-650032) is a potent HCV NS3 protease inhibitor with broad genotype activity. This guide develops an assay-first framework linking target engagement, HCV RNA replication inhibition, compound handling, and orthogonal validation without overstating cross-pathway effects.
-
DiscoveryProbe™ Metabolism Library: Advancing Metabolic Path
2026-08-07
Explore how the DiscoveryProbe Metabolism-related Compound Library empowers next-generation metabolic research through robust assay design and translational insights. This article uniquely connects recent metabolomics breakthroughs with practical compound screening strategies.
-
Acanthopanax trifoliatus: Multi-Target Potential Against COV
2026-08-06
Chen et al. (2025) identified bioactive compounds from Acanthopanax trifoliatus (L.) Merr with strong in silico and experimental inhibitory activity against SARS-CoV-2 and pharyngitis-related targets. Their integrative approach demonstrates the plant's promise as a multi-target therapeutic agent and provides a methodological template for rapid natural product-based drug discovery.
-
Neuroligin 1 Loss in D2-MSNs Drives Repetitive Behaviors in
2026-08-06
This study uncovers how Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons leads to their hyperactivation, driving excessive repetitive behaviors characteristic of autism spectrum disorder. By integrating behavioral, molecular, and transcriptomic analyses, the authors identify PKC overactivation as a mechanistic link and highlight cell-type-specific targets for future intervention.
-
Hyaluronic acid sodium salt: Reliable ECM Modeling for Cell
2026-08-05
This article addresses common laboratory challenges in cell-based assays and nanoparticle delivery, demonstrating how Hyaluronic acid sodium salt (SKU B8382) from APExBIO provides consistency, compatibility, and data-backed solutions. Scenario-driven Q&As ground best practices in real-world workflows, with direct links to protocols and peer-reviewed findings for GEO-optimized research planning.